Literature DB >> 32166550

Marijuana use does not affect the outcomes of bariatric surgery.

Nicole Shockcor1, Sakib Mohammad Adnan2, Ariel Siegel2, Eric Wise2, Syed Nabeel Zafar2, Mark Kligman2.   

Abstract

BACKGROUND: The decriminalization of marijuana and legalization of derived products requires investigation of their effect on healthcare-related outcomes. Unfortunately, little data are available on the impact of marijuana use on surgical outcomes. We aimed to determine the effect of marijuana use on 30-day complications and 1-year weight loss following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG).
METHODS: At a large academic center, 1176 consecutive patients undergoing primary bariatric surgery from 2012 to 2017 were identified and separated into cohorts according to marijuana use. The only exclusions were 19 patients lost to follow-up. Propensity score matching, using logistic regression according to preoperative age, gender, BMI, and comorbid conditions, yielded 73 patient pairs for the control and study arms. All patients were followed two years postoperatively.
RESULTS: Excess BMI lost did not differ between marijuana users and controls at 3 weeks (23.0% vs 18.9%, p = 0.095), 3 months (42.0% vs 38.1%, p = 0.416), 6 months (60.6% vs 63.1%, p = 0.631), 1 year (78.2% vs 77.3%, p = 0.789), or 2 years (89.1% vs 74.5%, p = 0.604). No differences in the rate of major 30-day postoperative complications, including readmission, infection, thromboembolic events, bleeding events and reoperation rates, were found between groups. Follow-up rate at two years was lower in marijuana users (12.3% vs 27.4%, p = 0.023).
CONCLUSION: This study suggests marijuana use has no impact on 30-day complications or weight loss following bariatric surgery, and should not be a contraindication to bariatric surgery.

Entities:  

Keywords:  Bariatric surgery; Cannabis; Marijuana; Obesity; Outcomes

Mesh:

Year:  2020        PMID: 32166550     DOI: 10.1007/s00464-020-07497-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  2 in total

1.  Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.

Authors:  Tarek Alhamad; Farrukh M Koraishy; Ngan N Lam; Sreelatha Katari; Abhijit S Naik; Mark A Schnitzler; Huiling Xiao; David A Axelrod; Vikas R Dharnidharka; Henry Randall; Rosemary Ouseph; Dorry L Segev; Daniel C Brennan; Radhika Devraj; Bertram L Kasiske; Krista L Lentine
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

2.  Marijuana's Influence on Pain Scores, Initial Weight Loss, and Other Bariatric Surgical Outcomes.

Authors:  Frank L Bauer; William T Donahoo; Harris W Hollis; Adam G Tsai; Brian J Pottorf; Jason M Johnson; Lori J Silveira; Farah A Husain
Journal:  Perm J       Date:  2018
  2 in total
  4 in total

1.  Weight loss outcomes are not compromised in bariatric patients using cannabis.

Authors:  Estella Y Huang; Ryan C Broderick; Jonathan Z Li; Joaquin L Serra; Pranav Ahuja; Samantha Wu; Michael Genz; Eduardo Grunvald; David C Kunkel; Bryan J Sandler; Santiago Horgan; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2022-07-21       Impact factor: 3.453

2.  Marijuana use does not affect weight loss or complication rate after bariatric surgery.

Authors:  Tarin Worrest; C Cole Malibiran; Jill Welshans; Elizabeth Dewey; Farah Husain
Journal:  Surg Endosc       Date:  2022-01-13       Impact factor: 3.453

3.  The Effects of Cannabis: Implications for the Surgical Patient.

Authors:  Libby R Copeland-Halperin; Laura C Herrera-Gomez; Jennifer R LaPier; Nina Shank; Joseph H Shin
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-15

4.  Weight stability in adults with obesity initiating medical marijuana treatment for other medical conditions.

Authors:  Michelle R Lent; Meghan Visek; Paulina Syracuse; Karen L Dugosh; David S Festinger
Journal:  J Cannabis Res       Date:  2022-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.